Category Archives: I-131-MIBG Treatment

Journal of Clinical Oncology Paper

This paper was published in the Journal of Clinical Oncology in September, 2009. My colleagues and I describe our experience treating 50 patients with high-dose 131I-MIBG for their malignant pheochromocytoma or paraganglioma. Download: Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy … Continue reading

Posted in I-131-MIBG Treatment | Leave a comment

UCSF MIBG Protocol

Here are files for the UCSF Phase II high-activity 131I-MIBG compassionate use protocol for treatment of patients having malignant pheochromocytomas or paragangliomas. MIBG Pheochromocytoma Protocol MIBG Pheochromocytoma Consent Document In order for 131I-MIBG therapy to achieve a remission for patients with malignant … Continue reading

Posted in I-131-MIBG Treatment | Leave a comment

Introduction to Pheochromocytoma and Paraganglioma

Pheochromocytomas are uncommon tumors that arise from cells of the sympathetic nervous system and may secrete catecholamines (adrenalin). Such tumors are usually found within one or both adrenal glands (90%), but may arise in other areas of sympathetic nerve cells, … Continue reading

Posted in I-131-MIBG Treatment | Leave a comment